How the FDA Can Harness Social Media for Improved Patient Access to Treatments & Clinical Trials

Below is a letter several of us wrote and submitted to the U.S. Food and Drug Administration around the U.S. Food and Drug Administration’s November 12 & 13, 2009, Advisory Committee Meeting hearing around the use of social media. Read more

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • LinkedIn
  • Live
  • MySpace
  • StumbleUpon
  • Technorati
  • Twitter
  • Yahoo! Bookmarks
Proudly using by